Playlist Mode Print Mode Enable Media Only

News chronological

10 items before 1153425 (Keyword: "cms" (~113 currently found))

YOUTUBE (Newsmax) - Dr. Oz Says $100 Billion a Year Is Lost to Medicare and Medicaid Fraud | Record Rewind

Healthcare fraud. Medicare costs. Obesity. GLP-1 drugs. Dr. Mehmet Oz joins Greta Van Susteren for a candid discussion about the biggest healthcare challenges facing America. In this special "Record Rewind" episode of "Greta Wire," Dr. Oz explains efforts to combat waste, fraud, and abuse within Medicare and Medicaid, discusses reforms designed to reduce paperwork and administrative burdens for doctors, and shares his views on lowering healthcare costs while improving patient outcomes. Greta and Dr. Oz also examine chronic disease, processed foods, obesity trends, healthcare technology, and the expanding role of GLP-1 medications in modern healthcare. CHAPTERS 0:33 Dr. Oz Joins Greta Wire 0:48 Fetterman, Politics & Common-Sense…

YOUTUBE (CNN) - The Medicaid economy: millions could lose coverage

The CBO estimates 5.3 million more people will be uninsured in 2034 because of a new Medicaid work requirement. Life is getting more expensive. What’s next? Stream CNN Breaks It Down for answers on the CNN app: https://cnn.it/4bZ6MRr #News

AXIOS (Adriel Bettelheim) - Medicare drug coverage faces an ominous spending outlook

There are troubling new signs that the overhaul of Medicare drug coverage in the Inflation Reduction Act is dramatically driving up program spending. Why it matters: The upward trajectory could threaten some seniors' coverage for outpatient prescription drugs — and it could force painful tradeoffs over the next decade as Medicare consumes a growing share of the nation's debt. Follow the money: The IRA limited what seniors have to pay for outpatient drugs and shifted the remaining cost to taxpayers, insurers who provide stand-alone Medicare drug plans and drug manufacturers. - That was good news for enrollees who take expensive drugs for conditions like cancer, multiple sclerosis or rheumatoid arthritis and faced potentially crushing…

YOUTUBE (Fox News) - Dr. Oz: This is RAMPANT FRAUD

CMS Administrator Dr. Mehmet Oz joins 'Fox & Friends' to discuss a major Medicare fraud crackdown, efforts to curb billions in healthcare fraud and the administration’s push to lower prescription drug costs through TrumpRx. #fox #foxnews #media #breakingnews #us #usa #new #news #breaking #foxandfriends #mehmetoz #oz #droz #cms #medicare #medicarefraud #healthcare #healthcarefraud #fraud #prescriptiondrugs #drugprices #trumprx #donaldtrump #trump #health #crime #crimenews #crimestory #criminal #police Don’t just watch Fox News—be part of it. Become a Fox News Patriot today. https://youtube.com/foxnews/join

JUSTTHENEWS (Amanda Head) - With Trump admin’s wizardry, Medicare gets new life under Oz

In 2026, 55% of those with Parts A and B used Medicare Advantage. Program spending was about $1.21 trillion in 2025 and near $1.3 trillion in 2026, up from $666 billion a decade earlier.

AMERICANTHINKER (American Thinker Blog) - Healthcare fraud in California reaches new low

By Deane Waldman Golden state-initiated legal fraud is a primary reason for rising insurance costs.

YOUTUBE (Fox Business) - COST CRACKDOWN: Dr Oz says Trump REFUSED to pay more than Europe, Asia for prescription drugs

CMS Administrator Dr. Mehmet Oz discusses President Donald Trump’s expanded drug discount deals with 26 drugmakers and explains how the agreements could save Americans more than $600 billion on ‘The Evening Edit.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theeveningedit #droz #mehmetoz #trump #donaldtrump #prescriptiondrugs #drugprices #healthcare #pharmaceuticals #manufacturing #investment #economy #drugcosts #medicare #cms #america

YOUTUBE (Newsmax) - Dr. Mehmet Oz: Trump providing $600 billion over next decade | American Agenda

CMS Administrator Dr. Mehmet Oz detailed President Trump's push to lower drug costs for Americans on Tuesday's "American Agenda."

REDSTATE (RedState) - Trump’s Drug Pricing Push Now Covers 89 Percent of Branded Market